← Evidence map

ArticleCancer science2018

Therapeutic strategies for afatinib-resistant lung cancer harboring HER2 alterations.

Hidejiro Torigoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29532558